|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:DIDO1-CTCF (FusionGDB2 ID:HG11083TG10664) |
Fusion Gene Summary for DIDO1-CTCF |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: DIDO1-CTCF | Fusion gene ID: hg11083tg10664 | Hgene | Tgene | Gene symbol | DIDO1 | CTCF | Gene ID | 11083 | 10664 |
| Gene name | death inducer-obliterator 1 | CCCTC-binding factor | |
| Synonyms | BYE1|C20orf158|DATF-1|DATF1|DIDO2|DIDO3|DIO-1|DIO1|dJ885L7.8 | CFAP108|FAP108|MRD21 | |
| Cytomap | ('DIDO1')('CTCF') 20q13.33 | 16q22.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | death-inducer obliterator 1death-associated transcription factor 1 | transcriptional repressor CTCF11 zinc finger transcriptional repressor11-zinc finger proteinCCCTC-binding factor (zinc finger protein)CTCFL paralog | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | P49711 | |
| Ensembl transtripts involved in fusion gene | ENST00000266070, ENST00000266071, ENST00000370371, ENST00000395335, ENST00000354665, ENST00000370366, ENST00000370368, ENST00000395340, ENST00000395343, | ||
| Fusion gene scores | * DoF score | 12 X 9 X 8=864 | 9 X 9 X 4=324 |
| # samples | 13 | 8 | |
| ** MAII score | log2(13/864*10)=-2.73251968913501 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/324*10)=-2.01792190799726 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: DIDO1 [Title/Abstract] AND CTCF [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | DIDO1(61569148)-CTCF(67605051), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | CTCF | GO:0000122 | negative regulation of transcription by RNA polymerase II | 8649389 |
| Tgene | CTCF | GO:0016584 | nucleosome positioning | 18654629 |
| Tgene | CTCF | GO:0045892 | negative regulation of transcription, DNA-templated | 8649389|18413740 |
| Tgene | CTCF | GO:0045893 | positive regulation of transcription, DNA-templated | 9407128 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-A2-A04Q-01A | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
Top |
Fusion Gene ORF analysis for DIDO1-CTCF |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-5UTR | ENST00000266070 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| 5UTR-5UTR | ENST00000266070 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| 5UTR-5UTR | ENST00000266071 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| 5UTR-5UTR | ENST00000266071 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| 5UTR-5UTR | ENST00000370371 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| 5UTR-5UTR | ENST00000370371 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| 5UTR-5UTR | ENST00000395335 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| 5UTR-5UTR | ENST00000395335 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000354665 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000354665 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000370366 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000370366 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000370368 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000370368 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000395340 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000395340 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000395343 | ENST00000264010 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| intron-5UTR | ENST00000395343 | ENST00000401394 | DIDO1 | chr20 | 61569148 | - | CTCF | chr16 | 67605051 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for DIDO1-CTCF |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| DIDO1 | chr20 | 61569147 | - | CTCF | chr16 | 67605050 | + | 1.46E-08 | 1 |
| DIDO1 | chr20 | 61569147 | - | CTCF | chr16 | 67605050 | + | 1.46E-08 | 1 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for DIDO1-CTCF |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:61569148/:67605051) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | CTCF |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Chromatin binding factor that binds to DNA sequence specific sites. Involved in transcriptional regulation by binding to chromatin insulators and preventing interaction between promoter and nearby enhancers and silencers. Acts as transcriptional repressor binding to promoters of vertebrate MYC gene and BAG1 gene. Also binds to the PLK and PIM1 promoters. Acts as a transcriptional activator of APP. Regulates APOA1/C3/A4/A5 gene cluster and controls MHC class II gene expression. Plays an essential role in oocyte and preimplantation embryo development by activating or repressing transcription. Seems to act as tumor suppressor. Plays a critical role in the epigenetic regulation. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, binding within the H19 imprinting control region (ICR) mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to IGF2. Plays a critical role in gene silencing over considerable distances in the genome. Preferentially interacts with unmethylated DNA, preventing spreading of CpG methylation and maintaining methylation-free zones. Inversely, binding to target sites is prevented by CpG methylation. Plays an important role in chromatin remodeling. Can dimerize when it is bound to different DNA sequences, mediating long-range chromatin looping. Mediates interchromosomal association between IGF2/H19 and WSB1/NF1 and may direct distant DNA segments to a common transcription factory. Causes local loss of histone acetylation and gain of histone methylation in the beta-globin locus, without affecting transcription. When bound to chromatin, it provides an anchor point for nucleosomes positioning. Seems to be essential for homologous X-chromosome pairing. May participate with Tsix in establishing a regulatable epigenetic switch for X chromosome inactivation. May play a role in preventing the propagation of stable methylation at the escape genes from X- inactivation. Involved in sister chromatid cohesion. Associates with both centromeres and chromosomal arms during metaphase and required for cohesin localization to CTCF sites. Regulates asynchronous replication of IGF2/H19. Plays a role in the recruitment of CENPE to the pericentromeric/centromeric regions of the chromosome during mitosis (PubMed:26321640). {ECO:0000269|PubMed:11743158, ECO:0000269|PubMed:16815976, ECO:0000269|PubMed:17827499, ECO:0000269|PubMed:18347100, ECO:0000269|PubMed:18413740, ECO:0000269|PubMed:18550811, ECO:0000269|PubMed:18654629, ECO:0000269|PubMed:19322193, ECO:0000269|PubMed:26321640, ECO:0000269|PubMed:8649389, ECO:0000269|PubMed:9591631}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for DIDO1-CTCF |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for DIDO1-CTCF |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DIDO1-CTCF |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for DIDO1-CTCF |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | DIDO1 | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
| Tgene | C3809686 | MENTAL RETARDATION, AUTOSOMAL DOMINANT 21 | 7 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
| Tgene | C0036341 | Schizophrenia | 1 | PSYGENET | |
| Tgene | C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | CTD_human | |
| Tgene | C0376407 | Granulomatous Slack Skin | 1 | CTD_human | |
| Tgene | C1860789 | Leukemia, Megakaryoblastic, of Down Syndrome | 1 | CTD_human | |
| Tgene | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | CTD_human | |
| Tgene | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies